ICON: ICON plc Schedules First Quarter 2025 Earnings Conference Call
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that it will release its financial results for the first quarter 2025 af...
Read full article »
ICON is an Ireland-based contract research firm that provides outsourced clinical development and commercialization services for sectors including pharmaceutical and biotech.
Read more